Latest filing published 12 Jun 2024 for Orthofix Medical Inc., €53k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Filings by Kimberley A. Elting span 2 companies, the busiest being Orthofix Medical Inc. and TriVascular Technologies, Inc. Between 3 February 2016 and 8 June 2024, the trades on record add up to 26 filings.
On the market, this insider has only ever bought: 1 purchase, €27k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 20 share grants and 2 option exercises.
The record was last updated on 12 June 2024 with a share grant (€53k) in Orthofix Medical Inc. The clock since the last published purchase (18 November 2021) now reads 1,795 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations